Inventor · disambiguated record
Jean-Guy Boiteau
Also filed as: BOITEAU JEAN-GUY · BOITEAU JEAN-GUY FRANCE
35 granted patents·16 pending applications·86 citations·filing 2002–2023
95Inventor score
Top patents by PatentIndex Score
51 records- 0194US11530301B2Carbohydrate crosslinkerGALDERMA SA·Filed 2016·Granted Dec 20, 2022·9 cites·11 claims
- 0293US11643509B2Carbohydrate crosslinkerGalderma Holding SA·Filed 2022·Granted May 9, 2023·1 cites·20 claims
- 0392US6803382B2Angiogenesis inhibitors and pharmaceutical and cosmetic use thereofGALDERMA RES & DEV·Filed 2002·Granted Oct 12, 2004·54 cites·17 claims
- 0487US2023416469A1Carbohydrate crosslinkerGalderma Holding SA·Filed 2023·Application pending·0 cites
- 0585US11780970B2Carbohydrate crosslinkerGalderma Holding SA·Filed 2023·Granted Oct 10, 2023·0 cites·20 claims
- 0685US9650337B2Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylateGALDERMA RES & DEV·Filed 2014·Granted May 16, 2017·3 cites·14 claims
- 0780US8513297B2Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereofBOITEAU JEAN-GUY·Filed 2012·Granted Aug 20, 2013·5 cites·27 claims
- 0877US8299259B24-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmeticsBOITEAU JEAN-GUY·Filed 2009·Granted Oct 30, 2012·3 cites·4 claims
- 0976US7863332B2Biaromatic compound activators of PPARγ receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Granted Jan 4, 2011·2 cites·50 claims
- 1075US11807726B2Method of crosslinking glycosaminoglycansGALDERMA RES & DEV·Filed 2021·Granted Nov 7, 2023·0 cites·4 claims
- 1172US10533061B2Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid and uses thereofGALDERMA SA·Filed 2015·Granted Jan 14, 2020·2 cites·17 claims
- 1272US8697726B24-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmeticsBOITEAU JEAN-GUY·Filed 2012·Granted Apr 15, 2014·2 cites·5 claims
- 1372US8372879B24-(heterocycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmeticsGALDERMA RES & DEV·Filed 2009·Granted Feb 12, 2013·1 cites·7 claims
- 1470US9580412B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2016·Granted Feb 28, 2017·1 cites·11 claims
- 1568US9526732B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 1668US8119674B24-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereofBOITEAU JEAN-GUY·Filed 2009·Granted Feb 21, 2012·1 cites·16 claims
- 1767US8796325B2Metronidazole esters for treating rosaceaBOITEAU JEAN-GUY·Filed 2011·Granted Aug 5, 2014·1 cites·12 claims
- 1865US11214655B2Method of crosslinking glycosaminoglycansGALDERMA RES & DEV·Filed 2017·Granted Jan 4, 2022·0 cites·4 claims
- 1961US7973063B2Methods for activating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Jul 5, 2011·0 cites·37 claims
- 2060US8993596B24-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmeticsGALDERMA RES & DEV·Filed 2014·Granted Mar 31, 2015·0 cites·23 claims
- 2158US10047172B2Single step functionalization and cross-linking of hyaluronic acidGALDERMA SA·Filed 2014·Granted Aug 14, 2018·0 cites·6 claims
- 2258US2014187532A14-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmeticsGALDERMA RES & DEV·Filed 2014·Application pending·0 cites
- 2357US8129416B2Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereofBOITEAU JEAN-GUY·Filed 2007·Granted Mar 6, 2012·0 cites·27 claims
- 2456US7626054B2Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2006·Granted Dec 1, 2009·0 cites·56 claims
- 2555US10988600B2Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereofGALDERMA SA·Filed 2017·Granted Apr 27, 2021·0 cites·17 claims
- 2655US9745281B2Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compoundsGALDERMA RES & DEV·Filed 2014·Granted Aug 29, 2017·0 cites·38 claims
- 2754US8404836B23-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereofBOITEAU JEAN-GUY·Filed 2009·Granted Mar 26, 2013·0 cites·44 claims
- 2854US2010160401A14-phenylimidazole-2-thione tyrosinase inhibitors and treatment or prevention of pigmentary disorders therewithGALDERMA RES & DEV BIOT FRANCE·Filed 2009·Application pending·0 cites
- 2954US2013303549A1Novel biaromatic compounds that modulate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2013·Application pending·0 cites
- 3054US2016129134A1Compositions comprising cross-linked hyaluronic acid and cyclodextrinGALDERMA SA·Filed 2014·Application pending·0 cites
- 3153US2009131660A1SYNTHESIS OF 3-[4-(1,1-DIMETHYL-PROPYL)-PHENYL]-2-METHYL-PROPIONALDEHYDE AND cis-4--2,6-DIMETHYL-MORPHOLINE (AMOROLFINE)GALDERMA SA·Filed 2008·Application pending·0 cites
- 3251US8357819B2Method for the synthesis of (Z)-3-[2-butoxy-3′-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acidGALDERMA RES & DEV·Filed 2008·Granted Jan 22, 2013·0 cites·19 claims
- 3351US7879907B23-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereofGALDERMA RES & DEV·Filed 2009·Granted Feb 1, 2011·0 cites·23 claims
- 3451US2008275274A1Process for the preparation of enantiomerically enriched compoundsDSM IP ASSETS BV·Filed 2008·Application pending·0 cites
- 3550US8383652B2Biaromatic compounds that modulate PPAR-receptorsGALDERMA RES & DEV·Filed 2008·Granted Feb 26, 2013·0 cites·34 claims
- 3650US7989483B24-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereofGALDERMA RES & DEV·Filed 2009·Granted Aug 2, 2011·0 cites·22 claims
- 3749US9908948B2Enantiopure or enantioenriched BDDE and its use as crosslinking agent in the manufacture of cross-linked productsGALDERMA SA·Filed 2015·Granted Mar 6, 2018·0 cites·7 claims
- 3849US9120772B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Sep 1, 2015·0 cites·6 claims
- 3949US2015191451A14-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmeticsGALDERMA RES & DEV·Filed 2015·Application pending·0 cites
- 4047US2007207175A1Biaromatic compound activators of PPARgamma receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Application pending·0 cites
- 4146US9408793B2Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositionsGALDERMA RES & DEV·Filed 2013·Granted Aug 9, 2016·0 cites·18 claims
- 4246US8802710B2Metronidazole esters for treating rosaceaBOITEAU JEAN-GUY·Filed 2011·Granted Aug 12, 2014·0 cites·13 claims
- 4343US2005245756A1Process for the preparation of enantiomerically enriched compoundsMINNAARD ADRIAAN J·Filed 2003·Application pending·0 cites
- 4442US9415039B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2015·Granted Aug 16, 2016·0 cites·8 claims
- 4542US2017196991A1Cyclodextrin-grafted hyaluronic acid crosslinked with dextran and uses thereofGALDERMA SA·Filed 2015·Application pending·0 cites
- 4641US10343999B2Method for synthesizing enantiomerically pure N-(pyridin-4-yl)-2-hydroxy-alkylamide derivativesGALDERMA RES & DEV·Filed 2016·Granted Jul 9, 2019·0 cites·9 claims
- 4741US2017210829A1Cross-linked polymer mixture of hyaluronic acid and dextran grafted with cyclodextrins and uses thereofGALDERMA SA·Filed 2015·Application pending·0 cites
- 4840US2020062868A1Method of crosslinking glycosaminoglycansGALDERMA RES & DEV·Filed 2017·Application pending·0 cites
- 4939US2020002441A1Method of crosslinking glycosaminoglycansGALDERMA RES & DEV·Filed 2017·Application pending·0 cites
- 5037US2013158090A1Metronidazole esters for treating rosaceaBOITEAU JEAN-GUY·Filed 2011·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jean-Guy Boiteau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →